Date Posted, by Alyssa Voss
In July, the Food and Drug Administration (FDA) approved the first blood test to use as primary screening for people at average risk for colon cancer. Although some experts said they are excited about the prospect of the Shield test to screen for colorectal cancer, they also cautioned that it’s unclear where the test fits in within the current screening paradigm for the disease, which includes other noninvasive screening options.